RecruitingNCT05630963
Brain receptor imaging and decision-making in current or past depression
About this title
Read the official source — NCT05630963Observational studyAges 18–45United States
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- BelmontSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 29, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 228
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT05630963
- Official title
Show the full official title
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including PET radiotracer.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as recruiting.
